Ligand profile
UEP
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: HT085_RS00140 — orotate phosphoribosyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
UEP- PDB
3ewu- UniProt (similar protein)
P11172- Target protein
- HT085_RS00140
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 171.3
- −1 ≤ LogP ≤ 5 -2.17
- MW ≤ 500 Da 352.2
- LogP ≤ 5 -2.17
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 171.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCC1=CC(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)OCCC1=CC(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O
InChI=1S/C11H17N2O9P/c1-2-5-3-7(14)12-11(17)13(5)10-9(16)8(15)6(22-10)4-21-23(18,19)20/h3,6,8-10,15-16H,2,4H2,1H3,(H,12,14,17)(H2,18,19,20)/t6-,8-,9-,10-/m1/s1InChI=1S/C11H17N2O9P/c1-2-5-3-7(14)12-11(17)13(5)10-9(16)8(15)6(22-10)4-21-23(18,19)20/h3,6,8-10,15-16H,2,4H2,1H3,(H,12,14,17)(H2,18,19,20)/t6-,8-,9-,10-/m1/s1
SVESMKHPINYNGL-PEBGCTIMSA-NSVESMKHPINYNGL-PEBGCTIMSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00215
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand UEP →
- PDB RCSB structure 3ewu →
- UniProt UniProt P11172 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “UEP”) →
Other ligands for this protein
Quick navigation to other ligands bound to HT085_RS00140.
PDB 18
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 4
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).